FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160407130> ?p ?o ?g. }

• W2160407130 endingPage "935" @default.
• W2160407130 startingPage "933" @default.
• W2160407130 abstract "NanomedicineVol. 9, No. 7 EditorialBioengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?Vipul B Gujrati & Sangyong JonVipul B GujratiKAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of KoreaSearch for more papers by this author & Sangyong JonKAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of KoreaSearch for more papers by this authorPublished Online:30 Jun 2014https://doi.org/10.2217/nnm.14.56AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: affibodycancer therapydrug deliveryouter membrane vesiclesmall interfering RNAReferences1 Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751–760 (2007).Crossref, Medline, CAS, Google Scholar2 Petros RA, Desimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615–627 (2010).Crossref, Medline, CAS, Google Scholar3 Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 3(1), 16–20 (2009).Crossref, Medline, CAS, Google Scholar4 Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10(7), 521–535 (2011).Crossref, Medline, CAS, Google Scholar5 Macdiarmid JA, Mugridge NB, Weiss JC et al. Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell 11(5), 431–445 (2007).Crossref, Medline, CAS, Google Scholar6 Wu W, Hsiao SC, Carrico ZM, Francis MB. Genome-free viral capsids as multivalent carriers for taxol delivery. Angew Chem. Int. Ed. 48(50), 9493–9497 (2009).Crossref, Medline, CAS, Google Scholar7 Tong GJ, Hsiao SC, Carrico ZM, Francis MB. Viral Capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J. Am. Chem. Soc. 131(31), 11174–11178 (2009).Crossref, Medline, CAS, Google Scholar8 Alvarez-Erviti L, Seow YQ, Yin HF, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29(4), 341-U179 (2011).Crossref, Google Scholar9 El Andaloussi S, Maeger I, Breakefield XO, Wood MJA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12(5), 348–358 (2013).Crossref, Google Scholar10 Gujrati V, Kim S, Kim SH et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano 8(2), 1525–1537 (2014).Crossref, Medline, CAS, Google Scholar11 Lee EY, Choi DS, Kim KP, Gho YS. Proteomics in Gram-negative bacterial outer membrane vesicles. Mass Spectrom. Rev. 27(6), 535–555 (2008).Crossref, Medline, CAS, Google Scholar12 Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Gene Dev. 19(22), 2645–2655 (2005).Crossref, Medline, CAS, Google Scholar13 Kim JY, Doody AM, Chen DJ et al. Engineered bacterial outer membrane vesicles with enhanced functionality. J. Mol. Biol. 380(1), 51–66 (2008).Crossref, Medline, CAS, Google Scholar14 Chen DJ, Osterrieder N, Metzger SM et al. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl Acad. Sci. USA 107(7), 3099–3104 (2010).Crossref, Medline, CAS, Google Scholar15 Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3(4), 354–359 (2002).Crossref, Medline, CAS, Google Scholar16 Somerville JE, Cassiano L, Darveau RP. Escherichia coli msbB gene as a virulence factor and a therapeutic target. Infect. Immun. 67(12), 6583–6590 (1999).Crossref, Medline, CAS, Google Scholar17 Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9(7), 463–475 (2009).Crossref, Medline, CAS, Google Scholar18 Orlova A, Magnusson M, Eriksson TLJ et al. Tumor Imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 66(8), 4339–4348 (2006).Crossref, Medline, CAS, Google Scholar19 Judge AD, Robbins M, Tavakoli I et al. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J. Clin. Invest. 119(3), 661–673 (2009).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByBacterial extracellular vesicle applications in cancer immunotherapyBioactive Materials, Vol. 22Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: Advances and perspectivesBioactive Materials, Vol. 14Nanoparticle-based medicines in clinical cancer therapyNano Today, Vol. 45Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancerAdvanced Drug Delivery Reviews, Vol. 186Outer membrane vesicles (OMVs) enabled bio‐applications: A critical review6 November 2021 | Biotechnology and Bioengineering, Vol. 119, No. 1Bacterial membrane vesicle functions, laboratory methods, and applicationsBiotechnology Advances, Vol. 54Microbiota–host communications: Bacterial extracellular vesicles as a common language13 May 2021 | PLOS Pathogens, Vol. 17, No. 5Host-derived extracellular vesicles for antimicrobial defense16 April 2021 | microLife, Vol. 2Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa6 May 2021 | International Journal of Molecular Sciences, Vol. 22, No. 9Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours16 March 2020 | Journal of Drug Targeting, Vol. 28, No. 7-8Engineered Bacterial Outer Membrane Vesicles as Multifunctional Delivery Platforms10 July 2020 | Frontiers in Materials, Vol. 7Cell membrane capsule: a novel natural tool for antitumour drug delivery7 March 2019 | Expert Opinion on Drug Delivery, Vol. 16, No. 3Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing5 September 2017 | Experimental and Therapeutic MedicineThe Therapeutic Benefit of Bacterial Membrane Vesicles16 June 2017 | International Journal of Molecular Sciences, Vol. 18, No. 6Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeuticsBiomaterials, Vol. 113How Our Other Genome Controls Our Epi-GenomeTrends in Microbiology, Vol. 24, No. 10The relationship between biofilm and outer membrane vesicles: a novel therapy overview24 July 2015 | FEMS Microbiology Letters, Vol. 362, No. 15 Vol. 9, No. 7 Follow us on social media for the latest updates Metrics Downloaded 344 times History Published online 30 June 2014 Published in print May 2014 Information© Future Medicine LtdKeywordsaffibodycancer therapydrug deliveryouter membrane vesiclesmall interfering RNAFinancial & competing interests disclosureThis research was supported by grants from the Bio & Medical Technology Development Program of the National Research Foundation (no. 2013035952) and by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Science, ICT & Future Planning (no. 2013M3A6A8073557). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2160407130 created "2016-06-24" @default.
• W2160407130 creator A5014183024 @default.
• W2160407130 creator A5041133038 @default.
• W2160407130 date "2014-05-01" @default.
• W2160407130 modified "2023-10-11" @default.
• W2160407130 title "Bioengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?" @default.
• W2160407130 cites W1975088956 @default.
• W2160407130 cites W1993804787 @default.
• W2160407130 cites W2012867962 @default.
• W2160407130 cites W2019615869 @default.
• W2160407130 cites W2026571103 @default.
• W2160407130 cites W2032760352 @default.
• W2160407130 cites W2036254354 @default.
• W2160407130 cites W2049044362 @default.
• W2160407130 cites W2050259218 @default.
• W2160407130 cites W2063954826 @default.
• W2160407130 cites W2066234893 @default.
• W2160407130 cites W2078895028 @default.
• W2160407130 cites W2080418767 @default.
• W2160407130 cites W2087670364 @default.
• W2160407130 cites W2106852013 @default.
• W2160407130 cites W2112236099 @default.
• W2160407130 cites W2120421571 @default.
• W2160407130 cites W2134450909 @default.
• W2160407130 cites W2155793921 @default.
• W2160407130 doi "https://doi.org/10.2217/nnm.14.56" @default.
• W2160407130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24978458" @default.
• W2160407130 hasPublicationYear "2014" @default.
• W2160407130 type Work @default.
• W2160407130 sameAs 2160407130 @default.
• W2160407130 citedByCount "21" @default.
• W2160407130 countsByYear W21604071302015 @default.
• W2160407130 countsByYear W21604071302016 @default.
• W2160407130 countsByYear W21604071302017 @default.
• W2160407130 countsByYear W21604071302019 @default.
• W2160407130 countsByYear W21604071302020 @default.
• W2160407130 countsByYear W21604071302021 @default.
• W2160407130 countsByYear W21604071302022 @default.
• W2160407130 countsByYear W21604071302023 @default.
• W2160407130 crossrefType "journal-article" @default.
• W2160407130 hasAuthorship W2160407130A5014183024 @default.
• W2160407130 hasAuthorship W2160407130A5041133038 @default.
• W2160407130 hasConcept C104317684 @default.
• W2160407130 hasConcept C121608353 @default.
• W2160407130 hasConcept C12554922 @default.
• W2160407130 hasConcept C126322002 @default.
• W2160407130 hasConcept C130316041 @default.
• W2160407130 hasConcept C146587185 @default.
• W2160407130 hasConcept C171250308 @default.
• W2160407130 hasConcept C185592680 @default.
• W2160407130 hasConcept C192562407 @default.
• W2160407130 hasConcept C2983331546 @default.
• W2160407130 hasConcept C41625074 @default.
• W2160407130 hasConcept C547475151 @default.
• W2160407130 hasConcept C55493867 @default.
• W2160407130 hasConcept C71924100 @default.
• W2160407130 hasConcept C86803240 @default.
• W2160407130 hasConceptScore W2160407130C104317684 @default.
• W2160407130 hasConceptScore W2160407130C121608353 @default.
• W2160407130 hasConceptScore W2160407130C12554922 @default.
• W2160407130 hasConceptScore W2160407130C126322002 @default.
• W2160407130 hasConceptScore W2160407130C130316041 @default.
• W2160407130 hasConceptScore W2160407130C146587185 @default.
• W2160407130 hasConceptScore W2160407130C171250308 @default.
• W2160407130 hasConceptScore W2160407130C185592680 @default.
• W2160407130 hasConceptScore W2160407130C192562407 @default.
• W2160407130 hasConceptScore W2160407130C2983331546 @default.
• W2160407130 hasConceptScore W2160407130C41625074 @default.
• W2160407130 hasConceptScore W2160407130C547475151 @default.
• W2160407130 hasConceptScore W2160407130C55493867 @default.
• W2160407130 hasConceptScore W2160407130C71924100 @default.
• W2160407130 hasConceptScore W2160407130C86803240 @default.
• W2160407130 hasIssue "7" @default.
• W2160407130 hasLocation W21604071301 @default.
• W2160407130 hasLocation W21604071302 @default.
• W2160407130 hasOpenAccess W2160407130 @default.
• W2160407130 hasPrimaryLocation W21604071301 @default.
• W2160407130 hasRelatedWork W1638339816 @default.
• W2160407130 hasRelatedWork W1992457817 @default.
• W2160407130 hasRelatedWork W2000345005 @default.
• W2160407130 hasRelatedWork W2031884754 @default.
• W2160407130 hasRelatedWork W2039789500 @default.
• W2160407130 hasRelatedWork W2040942865 @default.
• W2160407130 hasRelatedWork W2089302916 @default.
• W2160407130 hasRelatedWork W2895780579 @default.
• W2160407130 hasRelatedWork W2922253088 @default.
• W2160407130 hasRelatedWork W2183256402 @default.
• W2160407130 hasVolume "9" @default.
• W2160407130 isParatext "false" @default.
• W2160407130 isRetracted "false" @default.
• W2160407130 magId "2160407130" @default.
• W2160407130 workType "article" @default.